New Key Statistics Module, Z-Score and F-Score
XSAT:PMED Key Ratios
| Market Cap kr M | 20.29 |
| Enterprise Value kr M | 34.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.32 |
| Price/Sales | 0.39 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 39.00 |
| EPS (TTM) kr | -0.03 |
| Beneish M-Score | -3.5 |
| 10-y EBITDA Growth Rate % | 15.30 |
| 5-y EBITDA Growth Rate % | 17.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.77 |
| EV-to-EBITDA | -0.91 |
| PEG | -- |
| Shares Outstanding M | 1,989.61 |
| Net Margin (%) | -115.87 |
| Operating Margin % | -115.06 |
| Pre-tax Margin (%) | -115.88 |
| Quick Ratio | 0.50 |
| Current Ratio | 0.99 |
| ROA % (ttm) | -46.99 |
| ROE % (ttm) | -59.07 |
| ROIC % (ttm) | -55.92 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.55 |
XSAT:PMED Number of Guru Trades
XSAT:PMED Volume of Guru Trades
Gurus Latest Trades with XSAT:PMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:PMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers